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Abbreviations.
DR.................................... Death Receptor
BH................................. . Bcl-2 Homology
D D ................................... Death Domain
MPT................................. Mitochondrial Permeability Transition
ROS................................. Reactive Oxygen Species
AIF................................... Apoptosis Inducing Factor
PTPC................................ Permeability Transition Pore Complex
VDAC.............................. Voltage Dependent Anion Channel
ANT................................. Adenine Nucleotide Translocase
Smac................................ Second Mitochondrial Activator of Caspases
DIABLO..........................Direct IAP-Binding Protein of Low isoelectric point [pi]
LAP................................... Inhibitor of Apoptosis
IM .................................... Inner Membrane
OM................................... Outer Membrane
A'F.................................... Mitochondrial Membrane Potential
CsA.................................. cyclosporine A
Rhl23............................... Rhodamine 123
DRhl23............................ Dihydrorhodamine 123
Resorufin................. .......N-acetyl-8-dodecyl-3,7-dihyroxyphenoxazine
HEPES.............................N-2-hydroxyethyl piperazine-N’-2-ethansulfonic acid
MTT+............................... (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide
PI.......................................Propidimn Iodide
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Introduction.
General features of programmed cell death.
Apoptosis, or programmed cell death is recognized as a critical element in the removal of 
cells following exposure to toxic compounds as well as during development and in 
degenerative disorders. In general programmed cell death represents a continuum of cell death 
ranging from classical apoptosis to necrosis at its two poles. Apoptosis is a common and 
evolutionary conserved mechanism present in most living organism. Tissue homeostasis relies 
on the tightly controlled removal of superfluous, damaged and ectopic cells through 
apoptosis. Whereas an aberrant resistance to apoptosis participates in the development of 
neoplasia, excessive cell death, through apoptosis contributes to acute organ failure as well as 
to chronic diseases involving the loss of post-mitotic cells.
Recently, much progress has been made towards elucidating the various signal 
transduction pathways that can ultimately lead to a cell’s demise. Based on this information, 
many apoptotic cascades have been described, such as intrinsic and extrinsic, mitochondrial 
and death receptor (DR), p53-dependent and independent pathways in association with 
initiation, commitment and execution phase. It has become increasingly apparent that 
apoptosis is not a series of series of clearly defined pathways, but rather, a multitude of highly 
regulated , interconnected pathways. While trying to view any of these pathways in isolation 
is clearly an oversimplification, the sheer magnitude of possible events makes it a necessity.
The intrinsic cell death pathway involves the initiation of apoptosis as a result of a 
disturbance of intracellular homeostasis. In this pathway, mitochondria are critical for the 
execution of cell death, and so this pathway has been referred to as the mitochondrial cell 
death pathway. The extrinsic pathway involves the initiation of apoptosis through ligation of 
plasma membrane DRs, and so this pathway is also referred to as the DR pathway. While the
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initiation mechanism of these pathways are different, both converge to result ultimately in 
cellular morphological and biochemical alterations characteristic of apoptosis. It is also 
apparent that a considerable interaction between the pathways occur upstream of the 
convergence point, and that individual cells possess a considerable degree of redundancy in 
their apoptotic pathways. The main apoptotic cascade components and their most important 
features are described in the following.
Caspases.
Caspases (cystein apartate-specific proteases) are a family of intracellular proteins involved in 
the initiation and execution of apoptosis (Wolf and Green, 1999). Their activation is often 
referred to as the apoptotic commitment point. Caspases are synthesized as procaspases that 
are then proteolytically processed, at critical aspartate residues, to their active forms. All 
procaspases contain a highly homologues protease domain as well as an NH2 terminal 
prodomain. The induction of apoptosis through extrinsic or intrinsic death mechanisms results 
in the activation of initiator caspases. DRs, through adaptor molecules, recruit initiator 
caspases 2, 8, or 10, while intrinsic death signal results in the activation of caspase 9. 
Activation of initiator caspases is the first step of a highly regulated, irreversible self 
amplifying proteolytic pathway. Initiator caspases are able to cleave procaspases, and thus are 
able to activate effector caspases (caspases 3, 6, and 7) or are able to amplify the caspase 
cascade by increased activation of initiator caspases. Effector caspases are common to both 
the extrinsic and intrinsic death pathways, and therefore, the ultimate morphological and 
biochemical hallmarks of apoptosis are relatively independent of the apoptotic inducer.
Bcl-2 family.
Members of the Bcl-2 family of intracellular proteins are essential mediators of cell survival 
and apoptosis (Cory and Adams, 2002). Both anti- and pro-apoptotic family members have 
been characterized and their classification is related to the presence or absence of Bcl-2
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homology (BH) domains. Four BH domain have been described. Bcl-2 and Bc1-Xl both 
contain all four BH domain, possess established roles in the inhibition of apoptosis, although 
their exact mechanism remains elusive. It has been proposed that anti-apoptotic Bcl-2 family 
members inhibit apoptosis by antagonizing the actions of proapoptotic family members. This 
antagonism is proposed to occur upstream of apoptosis-related mitochondrial alterations. Two 
subfamilies of pro-apoptotic Bcl-2 family members have been identified; the bax family (Bax, 
Bok, and Bak), containing BH1, BH2, and BH3, and the BH3-only family (Bid, Bim, Bik, 
Bad, Bmf, Hrk, Noxa, and PUMA). Similar to the anti-apoptotic family members, the exact 
mechanism of action of pro-apoptotic Bcl-2 family members is uncertain.
Death Receptors.
Cell surface DRs belong to the tumor necrosis factor receptor (TNFR) superfamily (Chen and 
Göddel, 2002). They transmit their apoptotic signals following binding of death ligands. 
These receptor -ligand complexes initiate apoptotic cascades within seconds of ligand 
binding and can result in apoptotic cell death within hours. The best characterized family 
members include Fas (also known as Apol or CD95); additional members are DR3 (or 
Apo3), DR4, DR5 (or Apo2), and DR6. These receptors are Type I transmembrane receptors 
characterized by extracellular cysteine-rich domains (CRD) and intracellular death domains 
(DDs). The DD consists of six antiparallel, amphipathic a-helices folded in a configuration 
that results in the surface exposure of a number of charged residues. Following receptor- 
ligand binding, receptor DDs interact. Subsequent to this activation of DRs, other DD- 
containing proteins are recruited and function as adaptor proteins in the signal transduction 
cascade. These adaptor proteins interact with a variety of other proteins to complete the DR 
signaling pathways.
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The role of mitochondria in apoptosis.
The intrinsic cell death pathways follow from proapoptotic signals resulting in a disruption of 
intracellular homeostasis, that is the signals for cell suicide originate within the cell (Green 
and Reed, 1998; Wang, 2001). The mitochondria are the primary intracellular initiation sites 
although the endoplasmatic reticulum has also been implicated. All cells harbor the latent 
ability to undergo programmed cell death. Under normal circumstances, apoptosis is 
suppressed, as a result of the rigorous compartmentalization of catabolic enzymes and their 
activators. Mitochondria play a major role in this subcellular partitioning of death-regulating 
biochemical signals (Penninger and Kroemer, 2003). For example, cytochrome c is confined 
to the mitochondrial intermembrane space preventing it from interacting with apoptotic- 
protease-activating factor 1 (Apaf-1), a cytosolic protein. Upon permeabilization or rupture of 
the outer mitochondrial membrane, cytochrome c binds to Apaf-1, leading to allosteric 
activation of procaspase-9. Caspase-9 then proteolytically activates caspase-3, one of the 
principal proteases that participates in the execution of cell death. Similarly, Smac/DLABLO 
(second mitochondrial activator of caspases/direct LAP-binding protein of low isoelectric 
point [pi]) and Omi/HtrA2, two intermembrane proteins, are normally physically separated 
from cytosolic inhibitors of apoptosis proteins (IAPs). Upon mitochondrial permeability 
transition (MPT), Smac/DLABLO and Omi/HtrA2 neutralize IAPs, and thus relive the IAP- 
mediated inhibition caspase-3 and -9. Two DNA-destroying enzymes, apoptosis inducing 
factor (AIF) and endonuclease G, are also normally confined to the mitochondrial 
intermembrane space, but following MPT they can move to the nucleus where they mediate 
chromatino lysis.
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MPT is a major event in physiological as well as pathological cell death, and not surprisingly, 
it is regulated at multiple levels (Zamzami et al., 1996). MPT can be induced by multiple pro- 
apoptotic second messengers (Fig. 1.), including Ca2+, reactive oxygen species (ROS), lipid 
messengers (e.g. ceramide and ganglioside GD3) and stress kinases. In addition it is 
facilitated by pro-apoptotic proteins from the Bcl-2 family, and is inhibited by anti-apoptotic 
Bcl-2-like proteins. MPT might involve the formation of protein-permeable pores by 
oligomers of Bax and Bak (two pro-apoptotic proteins of the Bcl-2 family), as well as the 
transient or permanent opening of a variety of different channels, including those contained in 
the permeability transition pore complex (PTPC), such as the voltage-dependent anion 
channels (VDAC) in the outer membrane and the adenine-nucleotide translocase (ANT) in the 
inner membrane. In addition to PTPC-dependent mechanisms, recent findings suggest that
Mitochondrial Permeability Transition (MPT).
apoptotic proteins such as cytochrome c can be released from the mitochondria by as yet
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Fig.1. The importance of mitochondrial membrane permeabilization in apoptosis. 
Different apoptogenic molecules act on a variety of tenetively identified MPT 
regulator. MPT has several functional consequence resulting in cell death via both 
caspase-dependent and caspase-independent death effectors.
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undetermined mechanisms that do not involve formation of PTPC. Furthermore, different K+- 
selective channels in the inner membrane might control the volume of the mitochondrial 
matrix and ultimately the intactness of mitochondrial membranes. Moreover, inner-membrane 
uncoupling proteins (UCPs), which regulate the transmembrane proton gradient and the 
production of ROS and ATP, are increasingly being recognized for their roles in modulating 
cell death. Irrespective of the exact mechanism of MPT, it appears that this event can mark 
the ‘point of no return’ in the cell death process.
The mechanism o f mitochondrial permeability transition (MPT).
Mitochondria are organelles with two well-defined compartments: the matrix, surrounded by 
the inner membrane (IM), and the intermembrane space, surrounded by the outer membrane 
(OM). The IM is folded into numerous christae, which greatly increases its surface area. It 
contains the protein complexes from the electron transport chain, the ATP synthase and the 
adenine nucleotide translocator (ANT). To function properly, the IM is almost impermeable 
to the various metabolites in physiological conditions (except for the those that have regulated 
transport mechanism), thereby allowing the respiratory chain to create an electrochemical 
gradient (AT1). The A'F results from the respiration-driven, electron-transport-chain-mediated 
pumping of protons out of the inner membrane and is indispensable for driving the ATP 
synthase which phosphorylates ADP to ATP. ATP is then exported in exchange for ADP by 
the ANT. The OM in normal conditions is permeable to solutes up to about 5,000 Da. Thus, 
whereas the matrix space contains a highly selected set of small molecules, the 
intermembrane space is chemically equivalent to the cytosol with respect to low-molecular- 
weight solutes. The OM permeabilization involves the release of proteins which are normally 
confined to the intermembrane space, including cytochrome c, Smac/DIABLO, Omi/HtrA2 
and AIF. The IM permeabilization may occur in a ’step-wise’ manner (Green and Reed 1998; 
Bemardi 1999), with increasing permeability of solutes up to about 1,500 Da (Fig. 2.), and is
manifested as the dissipation of the proton gradient responsible for the trans-membrane 
potential (A'P), an extrusion of small solutes (such as calcium or glutation), or an influx of 
water and sucrose (which, in sucrose-containing media, leads to large-amplitude swelling of 
the matrix).
Fig. 2. Possible mechanisms of mitochondrial permeability transition (MPT).
The precise mechanisms of MPT are still unsolved and might depend on the initiating 
stimulus. Inhibitors of permeabilization are denoted in red and inducers are in green. 
Adenine-nucleotide translocase (ANT), voltage-dependent anion channel (VDAC) 
and cyclophillin D (CypD), as well as Bcl-2-like proteins, might be organized in 
higher-order molecular complexes, such as the so-called permeability transition pore 
complex (PTPC).
9
The role of mitochondrial permeablity transition (MPT) in diseases.
Mitochondria in acute neuronal death.
Ischemic strokes and traumatic injuries to the brain and spinal cord are responsible for the 
prolonged disability or death of millions ftiroughout the world. Studies of patient tissues and 
of animal models have shown, that mitochondria-mediated apoptosis is the mode of cell death 
of many neurons after an acute stroke or traumatic injury (Fiskum, 2000). Neurons are 
particularly sensitive to the oxygen and glucose deprivation that occurs during an ischemic 
stroke. Although neurons in the ischemic core die rapidly by necrosis, the majority of the 
neurons that die in the surrounding brain tissue (the penumbra) die by apoptosis. Several 
factors play a role in triggering MPT and neuronal apoptosis. Over-activation of receptors for 
the excitatory neurotransmitter, glutamate, under conditions of reduced energy availability 
results in excessive calcium accumulation ant the generation of ROS, both that can trigger 
MPT (Fig. 3.).
Fig. 3. The pivotal role of mitochondrial membrane permeabilization in 
neuronal death and chronic neurodegenerative disorders. In acute disorders 
neurons are deprived of oxygen and glucose, and are subjected to increased levels 
of neurotoxins released from damaged cells. In chronic disorders neuronal death is 
triggered by specific genetic mutations and/or environmental factors.
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The prevalence of chronic age-related neurodegenerative disorders like Alzheimer’s, 
Parkinson’s and Huntington’s disease is increasing rapidly. Cell cultures and animal models 
of these disorders, and studies of patients revealed that apoptosis involving MPT has a pivotal 
role in disease pathogenesis (Mattson, 2000). The factors that trigger apoptosis might differ 
among the neurodegenerative disorders (Fig. 3.), but each trigger appears to feed into a shared 
death cascade that involves increased oxidative stress and perturbed cellular energy and ion 
homeostasis. Stabilization of mitochondrial membranes by genetic manipulation of 
endogenous regulators of MPT or by treatment with pharmacological inhibitors of MPT 
suggest a necessary role for MPT in the pathogenesis of the neurodegenerative diseases. 
Mitochondria in myocardial cell death.
MPT is crucial to both acute and chronic degenerative cardiac myocyte death (Borutaite and 
Brown, 2003). Apoptosis might represent an acute ischemia-induced phenomenon, and an 
important mechanism of progressive myocardiocyte loss and left-ventricular remodeling 
resulting from heart failure. Inhibitory studies, mostly performed on isolated hearts subjected 
to ischemia reperfusion, indicate that PTCP components as well as mitochondrial ATP- 
sensitive potassium (mitoKATp) channels play a major role in acute heart muscle cell death. 
Opening of the PTPC is likely to be caused by ROS and by an increase in cytosolic Ca2+ 
levels, and reportedly involves enhancement of the interaction between ANT and cyclophilin 
D.
MPT and cancer.
The defects in the regulation of apoptosis contribute to the development of cancer. Cancer 
cells almost invariably acquire mutations that allow them to evade the normal signals and 
mechanisms that cause apoptotic cell death. Indeed, it has been argued that resistance to 
apoptosis is a necessary, although insufficient, step for malignant progression. Thus, for
Mitochondria in neurodegenerative disease.
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example, genetically modified mice that are compromised in their ability to engage one or 
more apoptotic pathway (and survive to adulthood) generally die prematurely of cancer. The 
induction of MPT in cancer cells by drugs therefore can be an effective method in the cancer 
therapy of the future.
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Objectives
Numerous drugs used in human therapy exert toxic effects on tissues and cells. Since the 
mitochondria is involved the apoptotic cell death process, we analyzed the effects of well 
known toxic drugs on the mitochondrial functions.
Taxol is a widely used antitumor agent (Horowitz, 1992). It stabilizes tubulin dimers, 
thus interfering with microtubular disassembly (Schiff et al, 1979), and resulting in the arrest 
of cells in G2-M phase of the cell cycle, followed by DNA fragmentation and morphological 
features of apoptosis. Paclitaxel has also been shown to activate Raf-1 and cause 
phosphorylation of Bcl-2 (Haidar et al., 1996; Ibrado et al., 1997), inactivating Bcl-2 and 
depriving it of forming heterodimers with the proapoptotic Bax (Haidar et al., 1995), hence 
leading to increased free intracellular Bax level. These effects of Taxol were exerted in the 
nM-jiM concentration range ususally after a 2-24 h exposure to the drug, with a tendency of 
longer exposure times for lower concentrations (Torres and Horowitz, 1998). Effect of 
paclitaxel on the mitochondrial permeability transition pore was also suggested to be 
mediated through interaction with the cytoskeleton (Evtodienko et al., 1996). Despite 
numerous studies, mechanisms of mitochondrial effect of paclitaxel still remains to be 
elucidated. Therefore, we studied the direct mitochondrial effects of paclitaxel, namely, the 
induction of mitochondrial ROS production, the collapse of mitochondrial membrane 
potential and the opening of mitochondrial permeability pore, aiming to provide a novel 
molecular mechanism for the cytotoxicity of paclitaxel that can explain its toxic effect in 
slowly replicating and non dividing cells.
Amiodarone, a class III antiarrhythmic agent prolongs action potential duration which 
effect may involve blocking of P-adrenergic receptors, sodium channels and L-type calcium 
channels (Singh and Vaughan Williams, 1970). It is one of the most effective antiarrhythmic
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drugs, and is frequently used in the clinical practice. However its administration is often 
limited by its toxic side effects, including pulmonary, liver and pancreas fibrosis, and thyroid 
dysfunction (Amico et al., 1984). The beneficial antiarrhythmic effect and the toxic effects on 
extracardiac tissues indicate a different sensitivity of the tissues toward amiodarone. However 
it has serious side effects limiting its clinical use. We analyzed if mitochondria plays a role in 
the beneficial cardiac and toxic extracardiac effects of amiodarone. and its major metabolite, 
N-desethylamiodarone. Conflicting reports appeared about the effect of the drug on cardiac 
functions in human studies (Remme and van Hoogenhuyze, 1990; Ellenbogen et al., 1985). 
Some reports presented beneficial effects of amiodarone during ischemia-reperfusion of 
perfused rat hearts (Karlson et al. 1990), whereas according to an other study, the drug 
improved hemodynamic parameters while it worsened the damages to the mitochondrial 
energy metabolism caused by ischemia-reperfusion (Moreau et al., 1999). The various results 
indicate that the molecular mechanism of the drug on cardiomyocyte function is poorly 
understood. In our study, we determined the effect of amiodarone on mitochondrial energy- 
metabolism during ischemia-reperfusion of Langendorff-perfiised rat hearts by in situ jlP- 
NMR spectroscopy. Assessing the direct effect of the drug on cardiac and extracardiac tissue, 
we determined the cytotoxicity of amiodarone on cells in culture. In an attempt to reveal the 
underlying mechanism of the drug in these paradigms, we studied its direct mitochondrial 
effects including induction of reactive oxygen species production, opening of PTP, and its 
effect on the mitochondrial respiration. We also compared the effect of amiodarone to other 
antiarrhythmic drug, and also to it’s major metabolite, N-desethyl-amiodarone.
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Materials and Methods.
Materials. Paclitaxel was from ICN Biomedicals Inc.; Taxol was from Bristol Myers Squibb; 
CsA was from Biomol Research Labs. Inc. ; rhodaminel23 (Rhl23), dihydrorhodaminel23 
(DRM23) and N-acetyl-8-dodecyl-3,7-dihydroxyphenoxazine (resorufin) were from 
Molecular Probes; amiodarone was from Chinoin Sanofi; all other compounds were from 
Sigma Chemical Co. unless otherwise stated.
Animals. Wistar rats kept under standardized conditions; tap water and rat chow were 
provided ad libitum. Animals were treated in compliance with approved institutional animal 
care guidelines.
Cell culture. PANC-1 human pancreatic epithelioid carcinoma cells, BRL 3 A rat liver cells, 
HepG-2 human hepatocellular carcinoma, WRL 68 human liver cells, H9C2 mouse 
cardiomyocytes and Sp-2 mouse myeloma cells were from American Type Culture 
Collection. PANC-1, BRL-3A, HepG-2, WRL 68 and H9C2 cells were cultured in DMEM 
containing 1% antibiotic-antimycotic solution (Sigma) and 10 % FCS. Sp-2 cells were 
cultured in RPMI 1640 medium containing L-glutamin (2 mM), penicillin (100 U/ml), 
streptomycin (100 pg/ml) and 10 % FSC. Cells were passaged at intervals of 3 days.
Isolation of mitochondria. Rat liver and heart mitochondria were prepared according to 
standard protocol (Schneider and Hageboom, 1950). The only difference among the organs 
were in their homogenization; liver and kidney were squeezed through a liver press, while 
pooled heart tissue from 5 rats was minced with a blender. Brain mitochondria was prepared 
as described (Sims 1990). Isolation of mitochondria from HepG-2 and BRL 3 A cells were 
performed exactly as described (Almeida and Medina, 1998). All isolated mitochondria were 
purified by Percoll gradient centrifugation (Sims 1990).
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Mitochondrial oxygen consumption was assessed by a Clark electrode. The mitochondrial 
respiration was measured in the presence of different concentrations of amiodarone or 
desethylamiodarone. Before performing experiments, RCR (respiratory control ratio) values 
of the mitochondria were determined and were found to be in the range of 2.1 ± 0.4 and 3.7± 
0.6 for the mitochondria from the heart or liver respectively (Elimandi et al., 1997;Garcia et 
al., 1997). State 3 and State 4 respiration as well as the respiratory control ratio and the 
ADP/O ratio were assessed from the original registration curve.
Mitochondrial permeability transition was monitored by following the accompanying large 
amplitude swelling via the decrease in absorbance at 540 nm (Cassarino et al., 1999) 
measured by a Perkin-Elmer fluorimeter in reflectance mode. Mitochondrial permeability 
transition was induced by the addition of 60 pM Ca2+ or of amiodarone at the indicated. 
Decrease of E540 and fluorescence intensity changes were detected for 20 min. The 
representative results demonstrated were selected from at least five independent experiments, 
each repeated three times, using mitochondria prepared from the same liver or pool of rat 
hearts respectively.
Enzymatic permeability transition assay. Measuring of citrate synthase (EC 4.1.3.7) and 
carnitine acyl transferase (EC 2.3.1.7) activity after the induction of permeability transition 
was performed as described (Korge and Weiss, 1999).
Alterations in the mitochondrial membrane potential following the induction of 
permeability transition was monitored by fluorescence of Rhl23, released from the 
mitochondria and detected by a Perkin-Elmer fluorimeter at an excitation wavelength of 495 
and an emission wavelength of 535 nm. Briefly, mitochondria at the concentration of 1 mg 
protein/ml were pre-incubated in the assay buffer containing 1 pM Rhl23 and the tested 
compounds for 60 seconds. Alteration of the mitochondrial membrane potential (A\j/) was 
induced by the addition of either 60 pM of Ca2+, or amiodarone or desethylamiodarone at the
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indicated concentrations. Changes of fluorescence intensity were detected for 4 min. The 
results are demonstrated by representative original registration curves from five independent 
experiments, each repeated three times using mitochondria prepared from the same liver or 
pool of rat hearts respectively
The determination of ROS-formation. ROS formation was detected as described (Varbiro 
et al., 2001) by the fluorescence of Rhl23 formed by ROS-induced oxidation of the non- 
fluorescent DRM23 in situ at an excitation wavelength of 495 nm and an emission 
wavelength of 535 nm by a Perkin-Elmer fluorimeter (London, UK). The ROS-induced 
oxidation of N-acetyl-8-dodecyl-3,7-dihydroxyphenoxazine forms N-acetyl-8-dodecyl- 
resorufin (resorufin) which exhibits strong red fluorescence. This product is well retained in 
living cells and organelles by virtue of its lipophilic tail, making it possible to detect ROS 
production in the lipid phase. The method is the same as described above except for changing 
the excitation wavelength to 578 nm and the emission wavelength to 597 nm. ROS-formation 
was calculated from the slope of the registration curves
Detection of cytochrome c release in vitro was performed as described. Samples from the 
cuvette were taken prior to, and 3 minutes after the induction of the permeability transition, 
and centrifuged at 15000 X g  for 15 minutes. Supernatants were analyzed for cytochrome c by 
Western blotting. Enhanced chemiluminescence labelling was used for the visualisation of the 
blots. Results are demonstrated by photomicrograph of a representative blot showing only the 
samples taken 3 minutes after the induction of the permeability transition.
Cell viability assay. PANC-1, BRL-3A, WRL 68 and H9C2 cells were seeded into 96-well 
plates at a starting density of 2.5 x 104 cell/well and cultured overnight. The following day, 
amiodarone at the indicated concentrations was added to the medium. Forty-eight hours later, 
0.5 % of the water soluble mitochondrial dye, (3-(4,5-dimethylthiazol-2-yl]-2,5-diphenyl- 
tetrazolium bromide (MTT+) was added. Incubation was continued for 3 more hours, the
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medium was removed, and the water insoluble blue formásán dye formed stochiometrically 
from MTT+ was solubilized by acidic isopropanol. Optical densities were determined by an 
ELISA reader (Anthos Labtech 2010) at 550 nm wavelength. All experiments were run in at 
least 4 parallels and repeated 3 times.
Oxygen consumption of cell lines H9C2, PANC-1 and BRL-3A were assessed by a Clark 
electrode (D’Aurelio et al., 2001,Beltran et al., 2002). The cells (1.5 x 107 cells per ml) were 
permeabilized by 50 pg/rnl digitonin to enable the penetration of the substrates and the 
different concentrations amiodarone.
DNA electrophoresis. Sp-2 and H9C2 cells at a starting density of 6 x 106 /10 cm plate were 
cultured in the presence of different concentrations of amiodarone for 24h, then were 
collected. Cell viability was assessed by the trypan blue dye exclusion method. DNA 
fragmentation was monitored by gel electrophoresis as described before (Gorczyca et al., 
1991). Electrophoresis was performed and DNA was visualized under UV light and 
photographed. Data presented as representative photomicrographs of at least three parallel 
experiments.
Demonstration of permeability transition in cultured cells. BRL 3A cells were seeded to 
glass coverslips (60 x 40 mm) at a starting density of 2500 cells/cm . The following day, 
CoverWell perfusion chambers were mounted on to the coverslips that allowed fast 
replacment of the medium on the cells. Cells were loaded with 1 pg/ml of Rhl23 dissolved in 
culture medium for 30 min at 37 °C. After three washes 20 pM paclitaxel alone or with 2.5 
pM CsA in KRH buffer containing 5 pg/ml propidium iodide (PI) was added. Incubation was 
continued under the microscope at room temperature, and fluorescent images were taken 
periodically.
The fluorescence of Rhl23 and PI was monitored using a Bio-Rad MRC-1024ES laser 
scanning confocal attachment mounted on a Nikon Eclipse TE-300 inverted microscope. Cells
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were excited with the 488 nm line of argon ion laser. Excitation light was passed through a 
dichroic mirror with a dividing wavelength of 527 nm preventing the exciting light to reach 
the detectors. The emitted fluorescent light was divided by a 565 nm dichroic mirror and was 
measured by separate photomultipliers through a 522/35 nm and a 680/32 nm band-pass filter. 
Laser intensity was attenuated by 99% in order to minimize photobleaching. Fluorescence 
was imaged with a Plan Apo 100x/1.4 oil-immersion objective. Confocal images were 
transferred to a Compaq Prosigna 300 workstation and were processed by using Bio-Rad's 
LaserSharp and Photoshop software packages. In this arrangement, green and red colour 
represents Rhl23 and PI fluorescence respectively.
Heart Perfusion. Rats weighing 350 g were pretreated with amiodarone or 
desethylamiodarone exactly as described previously (Nokin et al, 1987). Hearts were perfused 
via the aorta as described before (Szabados et al., 1999). After a washout (non-recirculating 
period of 15 min), hearts were perfused under normoxic conditions for 10 minutes; the flow 
was subsequently discontinued for 30 minutes by inflating a balloon (ischemia), which was 
followed by 15 minutes of reperfusion. Levels of high-energy phosphate intermediates were
'j i
monitored in the magnet of a P NMR spectroscope during the entire perfusion.
NMR Spectroscopy. NMR spectra were recorded with a Varian unityINOVA 400 WB 
instrument as described (Halmosi et al., 2000). Data were acquired from 5 independent 
experiment for sham-operated and amiodarone-treated groups each.
Western blot analysis of AIF. Myocardial specimens were snap-frozen immediately after 
surgical removal or at the end of the Lagendorff-perfusion experiment and stored at -80 °C 
until analyzed. Frozen heart muscle samples were mechanically homogenized in liquid 
nitrogen and the nuclear fraction was prepared as described (Schmitt et al., 2002). Equal 
amounts of nuclear extracts were separated by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (12% gel) and then transferred to a nitrocellulose filter. Membranes were
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blocked using 5% dry milk. The blot was probed with monoclonal antibodies against AIF 
overnight at the temperature of 4°C. The antigen-antibody complex was visualized on an X- 
ray film using secondary antibodies linked to horseradish peroxidase and a 
chemiluminescence kit. Results are demonstrated by photomicrograph of a representative 
blot.
Statistical analysis. Data were presented as means ± S.E.M. For multiple comparisons of 
groups ANOVA was used. Statistical difference between groups was established by paired or 
unpaired Student's t test, with Bonferroni correction.
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Results.
Paclitaxel induces MPT and dissipation o f A*F in isolated liver mitochondria. In a 
concentration dependent manner, paclitaxel induced swelling in isolated liver mitochondrion 
(Fig. 4.), in the presence of low concentration of Ca2+ (2.5 pM). This amount of Ca2+ did not 
induce permeability transition by itself. Paclitaxel at a concentration of 20 pM caused 
maximal swelling of mitochondria (same as induced by 150 pM Ca ) that was prevented
Liver Heart
* 4
Fig. 4. Permeability transition induced by different concentration of paclitaxel 
and 150 pM Ca2+ in isolated rat liver, heart, kidney and brain mitochondria.
Mitochondria in the presence or absence of CsA was incubated at room temperature 
in permeability transition-buffer as described in Materials and Methods. Permeability 
transition-inducing agents were added at arrow. Results are demonstrated by 
representative original registration curves for at least five independent experiments. 
Line 1: no agent added; line 2: 150 pM Ca2+; line 3: 10 pM paclitaxel; line 4: 20 pM 
paclitaxel; line 5: 20 pM paclitaxel + 2.5 pM CsA.
completely by 2.5 pM CsA. Twenty pM paclitaxel caused the dissipation of Ay (Fig. 5.), as 
detected by the release of the membrane potential sensitive dye, Rh 123 from liver 
mitochondria following the induction of permeability transition. Dissipation of A'F was 
inhibited by 2.5 pM CsA. The opening of the permeability transition pore allows the entering 
of substrates (such as acetyl-coenzyme A) that are otherwise excluded by the inner 
mitochondrial membrane into the mitochondrial matrix. It enabled us to demonstrate the 
opening of the permeability pore by a simple enzyme assay. Citrate synthase and carnitine 
acyltransferase activity become measurable using externally added acetyl-coenzyme A after
Liver Heart
Kidney Brain
Fig. 5. Changes in A*P induced by 20 |jM of paclitaxel and 150 pM Ca2+ in 
isolated rat liver, heart, kidney and brain mitochondria. Mitochondria in the 
presence or absence of CsA was incubated at room temperature in permeability 
transition-buffer as described in Materials and Methods. Permeability transition- 
inducing agents were added at arrow. Results are demonstrated by representative 
original registration curves for at least five independent experiments. Line 1: no agent 
added; line 2: 150 pM Ca2+; line 3: 20 pM paclitaxel; line 4: 20 pM paclitaxel + 2.5 pM 
CsA.
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the addition of either 150 pM Ca2+ or 20 pM paclitaxel showing the opening of the 
permeability pore. This effect was inhibited by 2.5 pM CsA. Release of cytochrome c from 
the mitochondrial intermembrane space following permeability transition induced by either 
150 pM Ca2+ or by 20 pM paclitaxel was detected by Western blotting. Cytochrome c release 
was inhibited in both cases by 2.5 pM CsA.
Paclitaxel induces MPT and dissipation o f A Y  o f mitochondria isolated in different 
tissues and cultured cells. The degree and slope of the swelling differed greatly among the 
different tissues, with the highest value for liver, a lower value for kidney and heart, a value 
close to the detection limit for brain and a swelling below detection limit for the cell lines (Fig 
4.). There were differences in the degree and slope of the Rhl23-release among the different 
tissues similar as in the case of swelling (Fig. 5.). However, measuring of Rh 123-release was 
much more sensitive than of swelling, so even for cell lines, the CsA-sensitivity of the Rhl23- 
release induced by either 20 pM paclitaxel or 150 pM Ca could be established.
Effect o f amiodarone and desethylamiodarone on Ca2+-induced MPT in isolated rat 
liver mitochondria. In isolated liver mitochondria, the swelling induced by 60 pM of Ca2+ 
was completely inhibited by 2.5 pM of CsA or by 1 pM of FCCP (data not shown). 
Depending on its concentration, amiodarone had a biphasic effect on mitochondrial swelling 
(Fig. 6.). Up to the concentration of 10 pM, amiodarone inhibited the rapid swelling induced 
by Ca2+ in a concentration dependent manner with the IC50 of 3.9 ± 0.8 pM. The most 
pronounced inhibitory effect of amiodarone on the swelling induced by 60 pM of Ca2+ was at 
the concentration of 10 pM. At higher concentrations, amiodarone proved to be less effective 
in delaying the Ca2+-induced swelling. In contrast to amiodarone, desethylamiodarone did not 
show any inhibitory effect on the mitochondrial permeability transition induced by 60 pM of 
Ca2+ up to the concentration of 10 pM (Fig. 6.).
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At concentrations above 10 pM, amiodarone induced mitochondrial swelling by its own (Fig. 
7.), that was not inhibited by 2.5 g.M of CsA. In contrast to 30 pM of amiodarone which 
developed swelling with a rate significantly slower than that of the Ca2+-induced swelling,
desethylamiodarone, at the concentration of 30 jiM induced swelling with a rate
Fig. 6. The effect of amiodarone or desethylamiodarone on Ca2+-induced 
mitochondrial swelling. Mitochondrial swelling was demonstrated by monitoring 
E540 in isolated rat liver mitochondria. Amiodarone (Ad) at the indicated concentration 
or 2.5 pM cyclosporin A (CsA) was present throughout the experiment(A). 
Alternatively desethylamiodarone (Dea) at the indicated concentration or 2.5 pM 
cyclosporin A (CsA) was present throughout the experiment (B). The mitochondrial 
permeability transition (swelling) was induced by adding 60 pM Ca2+ at arrow
(A) Line 1: baseline swelling (no agent); line 2: 60 pM Ca2+-induced swelling (no Ad 
or CsA); line 3: CsA; line 4: 1 pM Ad; line 5: 2.5 pM Ad; line 6: 5 pM Ad; line 7: 10 pM 
Ad; line 8: 20 pM Ad.
(B) Line 1: baseline swelling (no agent): line 2: 60 pM Ca2+-induced swelling (no Dea 
or CsA); line 3: CsA; line 4: 1 pM Dea; line 5: 2.5 pM Dea; line 6: 5 pM Dea; line 7: 
10 pM Dea; line 8: 20 pM Dea.
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similar to that of the Ca2+-induced one. The swelling induced by desethylamiodarone was not 
inhibited by 2.5 jiM of CsA (Fig. 7.). The effect of amiodarone or desethylamiodarone on
isolated rat heart mitochondria was basically the same, as on liver mitochondria
Fig. 7. The mitochondrial swelling induced by amiodarone or 
desethylamiodarone. Mitochondrial swelling was demonstrated by monitoring E54o 
in isolated rat liver mitochondria. Cyclosporin A (CsA), at the concentration of 2.5 pM, 
where indicated, was present throughout the experiment. Swelling was induced by 
adding amiodarone (Ad) at the indicated concentration (A) or desethylamiodarone 
(Dea) at the indicated concentration (B), or 60 pM Ca2+ at the arrow.
(A) Line 1: baseline swelling (no agent); line 2: 60 pM Ca2+-induced swelling (no Ad 
or CsA); line 3: 10 pM Ad; line 4: 10 pM Ad + CsA; line 5: 20 pM Ad; line 6: 20 pM 
Ad+ CsA; line 7: 30 pM Ad; line 8: 30 pM Ad + CsA.
(B) Line 1: baseline swelling (no agent); line 2: 60 pM Ca2+-induced swelling (no Dea 
or CsA); line 3: 10 pM Dea; line 4: 10 pM Dea + CsA; line 5: 20 pM Dea; line 6: 20 
pM Dea+ CsA; line 7: 30 pM Dea; line 8: 30 pM Dea + CsA.
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The opening of the permeability transition pore allows the entering of substrates (such 
as acetyl-coenzyme A) that are otherwise excluded by the inner mitochondrial membrane into 
the mitochondrial matrix. It enabled us to demonstrate the opening of the permeability pore 
by a simple enzyme assay. Citrate synthase and carnitine acyltransferase activity become 
measurable using externally added acetyl-coenzyme A after the addition of 60 pM of Ca 
showing the opening of the permeability pore. This effect was also delayed by 10 pM of 
amiodarone.
Effect o f  amiodarone and desethylamiodarone on dissipation o f A*F in isolated liver 
mitochondria. Sixty pM Ca caused the dissipation of AT*, as detected by the release of the 
membrane potential sensitive dye, Rhl23, from isolated liver mitochondria (Fig. 8.). When 
the mitochondrial membrane was depolarized by Ca2+ in the presence of 2.5 pM CsA, after a 
transient depolarization lasting for about a minute, AT* returned to the value identical to the 
one before the addition of Ca2+. Ten pM of amiodarone depolarized the mitochondrial 
membrane in a similar extent as did the 60 pM of Ca2+, however, its depolarizing effect was 
not influenced at all by 2.5 pM of CsA. Amiodarone caused a concentration dependent release 
of Rhl23 from liver mitochondria with a calculated EC5o value of 4.2 ± 0.7 pM. In contrast to 
this, desethylamiodarone, up to the concentration of 10 pM did not induce the dissipation of 
AT1. However, desethylamiodarone at the concentration of 20 pM caused Rhl23 release from 
the isolated mitochondria as did 20 pM of amiodarone, 60 pM of Ca2+, or as did 1 pM of 
FCCP. The calculated EC50 value for desethylamiodarone was 16.3 ± 2.3 pM. The 
depolarizing effect of 20 pM of desethylamiodarone was not influenced at all by 2.5 pM of 
CsA.
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Fig. 8. Effect of amiodarone or desethylamiodarone on the mitochondrial 
membrane potential in isolated mitochondria. Membrane potential was monitored 
by measuring the fluorescence intensity of the cationic fluorescent dye rhodamine 
123. Isolated rat liver mitochondria, added at the first arrow, takes up the dye in a 
voltage dependent mariner and quenches its fluorescence. Amiodarone (Ad), 
desethylamiodarone (Dea) at the concentrations indicated or 60 pM Ca2+ (either 
added at second arrow) induces depolarization resulting in release of the dye and 
increase of the fluorescence intensity. (A) Line 1: no agent; line 2: Ca2+; line 3: 10 pM 
Ad; line 4: Ca2+ + 2.5 pM CsA ; line 5: 10 pM Ad + 2.5 pM CsA; line 6: 10 pM Dea. 
(B) Line 1: no agent; line 2: 1 pM Ad; line 3: 2.5 pM Ad; line 4: 5 pM Ad; line 5: 10 pM 
Ad; line 6 : 20 pM Ad (C) Line 1: no agent; line 2: 1 pM Dea; line 3: 2.5 pM Dea; line 
4: 5 pM Dea; line 5: 10 pM Dea; line 6: 20 pM Dea.
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Paclitaxel induces dissipation o f A Y  in cell line. Confocal microscopy was used to monitor 
the changes in Rhl23 and PI fluorescence images of BRL-3A cells (Fig. 9.). The cationic dye, 
Rhl23 is retained by the mitochondria and shows green fluorescence image of the 
mitochondria when Ay is intact, but is released into the cytosol and shows a weak background 
fluorescence when A\|/ is disrupted in consequence to permeability transition. On the other 
hand, PI is excluded by intact cell membranes, but shows red fluorescent image of the nucleus 
when cellular energy charge drops to zero or the integrity of the cell membrane is damaged. 
Representative fluorescent images taken 45 minutes after the addition of paclitaxel
Fig. 9. Demonstration of permeability transition in BRL-3A cell line. Confocal 
fluorescent microscopy images of Rh123 (green) and PI (red) fluorescence were 
taken periodically. Cells cultured on coverslips were loaded with Rh123, washed, and 
incubated in medium containing 5 pg/ml PI in the absence or the presence of 20 pM 
paclitaxel together with or without 2.5 pM CsA as described in Methods. 
Representative double-fluorescence photos taken after 45 min of incubation are 
presented. A: no agent; B: 20 pM paclitaxel; C: 20 pM paclitaxel+2.5 pM CsA.
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and CsA demonstrate the effect of these drugs on the cells. Green fluorescent dots of 
approximately the same intensity representing mitochondria were seen in each control cell. 
This pattern of uniform fluorescent intensity was maintained in control cells for several hours. 
When the cells were incubated for about 35 minutes in the presence of 20 fiM paclitaxel, 
mitochondria in the cells started to undergo permeability transition which process was 
completed in 20 minutes indicated by a complete disappearance of green fluorescence. We 
demonstrated an intermediate state, when the green fluorescent intensity was decreased in 
some cells, completely disappeared in other cells and red PI fluorescence of a nucleus 
appeared in a cell indicating that permeability transition took place in the mitochondria of 
some cells as a consequence of 45 min incubation with 20 pM paclitaxel. CsA at a 
concentration of 2.5 pM inhibited the permeability transition-inducing effect of paclitaxel as 
revealed by fluorescent images identical to control.
Paclitaxel induces ROS formation in isolated rat liver mitochondria. Since ROS formation 
can induce the mitochondrial permeability transition, we studied the effect of paclitaxel on 
ROS production in isolated, Percoll gradient-purified rat liver mitochondria. ROS formation 
was measured by monitoring the green or red fluorescence of Rhl23 or resorufin oxidized by 
the ROS from non-fluorescent DRhl23 or N-acetyl-8-dodecyl-3,7-dihydroxyphenoxazine in 
situ, respecively (Fig. 10.). By virtue of its dodecyl group, resorufin was localized in 
membranous regions and detected ROS formation in lipid phase while Rhl23 reflected to 
ROS levels in aqueous phase. Paclitaxel induced ROS-formation in isolated liver 
mitochondria in a concentration dependent manner. By using both dyes, we compared the 
ROS-formation induced by paclitaxel to that of 50 mM H2O2. A much more intense ROS- 
formation was detected by resorufin (61 ±  6.4 % that of 50 mM H2O2) than by Rhl23 (21 ± 
4.7 % that of 50 mM H2O2). When detected by Rhl23, ROS formation induced by paclitaxel 
could be attenuated by 1 mM lipoamide, 1 mM ascorbic acid and in a smaller extent by 100
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jiM tocopherol, however, not by 1 mM N-acetyl-L-cysteine. ROS formation induced by 
paclitaxel was decreased by 1 mM lipoamide, 100 jiM tocopherol and in a smaller extent by 1
Fig. 10. ROS-formation in isolated mitochondria. Increase of fluorescence 
intensities of resorufin (A) and Rh123 (B) oxidized from non-fluorescent N-acetyl-8- 
dodecyl-3,7-dihydroxyphenoxazine and DHRh123 by ROS was measured as 
described in Materials and Methods. Resorufin and Rh123 fluorescence reflected to 
the paclitaxel induced ROS formattion in the aquous and the lipid phase respectively. 
Results were calculated from the slope of the original registration curves (fluorescent 
intensity vs. time) and expressed as % of the ROS-formation in the absence of 
paclitaxel. Values are mean ± S.E.M. of at least 5 independent experiments.
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mM N-acetyl-L-cysteine, however, not by 1 mM ascorbic acid when detected by resorufin. 
Selective inhibitors of the respiratory complexes caused a transient fast increase of the 
mitochondrial ROS formation followed by a plateau where the rate of ROS formation was the 
same as before the addition of the given substance. When added on this plateau, paclitaxel 
induced ROS formation with a time-course similar to that observed in the absence of the 
inhibitors of the respiratory chain. However, KCN and other inhibitors of cytochrome 
oxidase, azide and NO, inhibited the paclitaxel-induced ROS production. Ca2+ at the 
concentration of 150 |j.M did not induce ROS formation, furthermore, the ROS formation 
induced by either 50 pM paclitaxel or 50 mM H2O2 could not be inhibited by 2.5 pM CsA.
The effect o f amiodarone and desethylamiodarone on ROS formation in isolated rat 
mitochondria. Up to the concentration of 100 pM, amiodarone and desethylamiodarone did 
not induce ROS formation in mitochondria isolated from either liver or heart as detected by 
Rhl23 or resorufin.
Effect o f paclitaxel on mitochondrial oxygen consumption. Since inhibitors of the 
respiratory chain caused a transient ROS formation, we checked whether paclitaxel had 
inhibitory effect on mitochondrial respiration. Oxygen consumption was measured by using a 
Clark electrode in isolated rat liver mitochondria. Paclitaxel up to the concentration of 20 pM 
either alone, or in combination with up to 500 pM Ca2+ did not decrease the oxygen 
consumption supported by either succinate, or pyruvate under our experimental conditions. 
Effect o f amiodarone and desethylamiodarone on the mitochondrial oxygen consumption. The 
oxygen consumption of isolated mitochondria (state 4 respiration) was measured by a Clark 
electrode, with 10 mM pyruvate (Complex I supported respiration) or 10 mM succinate in the 
presence of 1 pM rotenone (Complex II supported respiration) exposed to different 
concentrations of amiodarone or desethylamiodarone (Fig. 11). In isolated rat heart 
mitochondria, at low concentrations, amiodarone did not have a significant effect either on
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Complex I or on Complex II supported respiration, as compared to the control. In an
Fig. 11. The effect of amiodarone and desethylamiodarone on mitochondrial 
oxygen consumption. Mitochondrial respiration was measured by a Clark electrode 
and was supported with either 10 mM pyruvate (Complex I respiration) or 10 mM 
succinate (Complex II respiration) in the presence of different concentrations of 
amiodarone or desethylamiodarone. Data represents average ± S.E.M. of three 
independent experiments repeated twice using mitochondria prepared from the same 
heart samples. Note that the concentration axis is logarithmic. *, significant difference 
(p < 0.05; mean ± S.E.M., paired t test); **, significant difference (p < 0.01; mean ± 
S.E.M., paired t test); ***, significant difference (p < 0.001; mean ± S.E.M., paired t 
test) of amiodarone or desethylamiodarone from control.
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intermediate concentration range amiodarone increased both the Complex I- and Complex II- 
supported oxygen consumption indicating an uncoupling effect, while, the drug gradually 
inhibited respiration at higher concentrations.
Desethylamiodarone did not have any significant effect on the mitochondrial oxygen 
consumption at low concentrations of up to 10 pM. Above this concentration it gradually 
inhibited the respiration supported by succinate and in the concentration above 30 pM the 
respiration supported by pyruvate, without presenting an uncoupling effect, as indicated by 
the absence of the stimulation of both Complex I- and Complex D-supported respiration in the 
concentration range of 6 to 30 pM. Above 30 pM, desethylamiodarone inhibited Complex I 
supported respiration, similarly to that observed with equimolar concentrations of 
amiodarone. However, above the concentration of 30 pM, desethylamiodarone presented a 
significantly stronger inhibition (p< 0.01) on Complex II supported respiration, than the one 
observed with equimolar concentrations of amiodarone. The effect of amiodarone or 
desethylamiodarone on isolated rat liver mitochondria was basically the same.
Amiodarone induces internucleosomal fragmentation o f genomic DNA. Following 
exposure of Sp-2 cells to different concentrations of amiodarone for 24 h, internucleosomal 
DNA fragmentation and the morphological features of apoptosis were detected from the 
concentration of 1 pM or higher. However, in H9C2 cells no DNA-laddering was observed in 
the presence of amiodarone up to the concentration of 30 pM (Fig. 12.).
Effect o f amiodarone and desethylamiodarone on the viability o f cultured cell lines. 
Viability of H9C2, BRL-3A, WRL-68 and PANC-1 cells exposed to different concentrations 
of amiodarone or desethylamiodarone for 48h were assessed by the MTT+ method (Fig. 13). 
In all cell lines desethylamiodarone proved to be more toxic than amiodarone in a specific 
concentration range. This concentration range seemed to be variable in the different cell lines. 
The significant difference (p < 0.001) between the toxicity of amiodarone and
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desethylamiodarone observed in H9C2 cardiomyocytes was in a concentration range between 
10 to 60 pM. In the normal rat (BRL-3A) and human (WRL-68) liver cell lines the significant 
difference (p < 0.001 and p < 0.01 respectively) between the toxicity of the drugs appeared in 
a lower concentration range between 3 to 20 pM. In PANC-1 human pancreatic epithelioid 
carcinoma cells, significant difference (p < 0.01) between the toxicity of amiodarone and 
desethylamiodarone was observed in a concentration range of 20 to 80 pM as revealed by the 
viability data. The various cell lines presented different sensitivity towards the toxicity of 
amiodarone or desethylamiodarone. The drugs were shown to be the least toxic in H9C2 
cardiomyocyte cells. BRL-3A and WRL-68 hepatocytes were much more sensitive to 
amiodarone or desethylamiodarone toxicity than the PANC-1 human pancreatic epithelioid 
carcinoma cells, however, BRL-3A and WRL-68 were normal, while PANC-1 was a cancer 
cell line.
Fig. 12. The effect of amiodarone on apoptosis in SP-2 cells. Amiodarone- 
induced DNA fragmentation analysis (B) was performed by separating the total DNA 
content of SP-2 cells exposed to different concentrations of Ad for 24 hours by 
agarose gel electrophoresis. Lane 1: Marker; lane 2: no Ad; lane 3: 1 pM Ad; lane 4:
3 pM Ad; lane 5: 10 pM Ad; lane 6: 30 pM Ad;
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Fig. 13. The effect o f amiodarone and desethylamiodarone on viability of cell 
lines. The effect of amiodarone (open bars) and desethylamiodarone (filled bars) on 
viability of H9C2 (A), BRL-3A (B), WRL-68 (C) and HeLa cells (D) were detected by 
the formation of water insoluble blue formásán dye from the yellow mitochondrial 
dye, MTT+ by the functionally active mitochondria of the cells. The cells were 
exposed to different concentrations of amiodarone or desethylamiodarone for 48 
hours before the addition of the MTT+ dye. Data represents average ± S.E.M. of three 
independent experiments running in 4 parallels. **, significant difference (p < 0.01; 
mean ± S.E.M., paired t test); ***, significant difference (p < 0.001; mean ± S.E.M., 
paired t test) of amiodarone from equimolar concentrations of desethylamiodarone.
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When H9C2 cardiomyocytes were exposed to different concentrations of amiodarone, 
desethylamiodarone or FCCP for only lh  (Fig. 14.), the results detected by the formation of
H9C2
WRL-68
4 —  Ad —■- -Dea - - A -  Fccp
Fig. 14. The effect of amiodarone, desethylamiodarone and FCCP on the 
cellular respiration. The effect of amiodarone, desethylamiodarone and FCCP on 
respiration of H9C2 (A) and WRL-68 (B) cells were detected by the formation of 
water insoluble blue formásán dye from the yellow mitochondrial dye, MTT+ by the 
functionally active mitochondria of the cells. The cells were exposed to different 
concentrations of amiodarone, desethylamiodarone or FCCP for 1 hours before the 
addition of the MTT+ dye. Data represents average ± S.E.M. of three independent 
experiments running in 4 parallels. +++, significant difference (p < 0.001; mean ± 
S.E.M., paired t test) of FCCP from equimolar concentrations of amiodarone; ***, 
significant difference (p < 0.001; mean ± S.E.M., paired t test) of desethylamiodarone 
from equimolar concentrations of amiodarone.
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water insoluble blue formásán dye from the yellow mitochondrial dye, MTT+ by the 
functionally active mitochondria reflect the respiratory state, rather than the number of viable 
cells. Amiodarone, up to the concentration of 30 pM, exerted an uncoupling effect as 
indicated by the increase of optical densities, similarly to that of the equimolar concentrations 
of FCCP, a widely used uncoupling agent. However, at the concentration of 100 jiM, the 
stimulatory effect of amiodarone declined significantly (p < 0.001), when compared to 
equimolar concentrations of FCCP (114% ± 7 vs 141% ± 6). Desethylamiodarone did not 
exhibit any stimulatory effect on the respiration, when present in low concentrations, whereas 
it significantly (p < 0.001) decreased the MTT+ formation, when compared to equimolar 
amount of amiodarone above the concentration of 10 |iM. In WRL-68 liver cells, amiodarone, 
did not show any stimulatory effect up to the concentration of 30 pM, while it decreased the 
respiration, when present in higher concentration. The effect of both desethylamiodarone and 
FCCP on the respiration of WRL-68 were similar like in the case of H9C2, with 
desethylamiodarone showing inhibition, while FCCP manifesting an uncoupling effect above 
the concentration of 10 pM. The values of the optical densities in this concentration range for 
both desethylamiodarone and FCCP were significantly different (P < 0.001) from those of the 
equimolar concentrations of amiodarone.
Effect o f amiodarone and desethylamiodarone on the energy metabolism during ischemia- 
reperfusion in perfused hearts. Concentrations of high-energy phosphate intermediates were 
monitored during ischemia-reperfusion in Langendorff-perfused hearts by using 31P NMR 
spectroscopy (Fig. 15.). In order to study the effect of amiodarone or desethylamiodarone on 
the energy-metabolism of the perfused hearts, a single i.v. injection of 20 mg/kg amiodarone 
or 20 mg/kg desethylamiodarone was administered to a group of rats 30 min before the start 
of the heart-perfusion, a protocol that was previously reported to be optimal for 
cardioprotection by amiodarone. Thirty minutes of global ischemia induced the disappearance
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of creatine phosphate and ATP, and a gradual increase of inorganic phosphate signal. During 
reperfusion, all hearts restarted working, while creatine phosphate concentrations in hearts of 
sham-operated animals recovered to 35% ± 4 of their normoxic
39
level. Amiodarone pretreatment resulted in a significantly higher recovery (p < 0.001) of 
creatine phosphate concentrations during the ischemia-reperfusion cycle (74% ± 6) when 
compared to control (35% ± 4), while the pretreatment with desethylamiodarone had no 
significant effect on the recovery of creatine phosphate concentration following ischemia 
(32% ± 4). In addition, amiodarone pretreatment slightly but significantly (p < 0.05) delayed 
the decrease of ATP concentrations during ischemia, while significantly (p < 0.001) improved
-♦-Sham-operated -■-Amiodarone -±-Dea
Fig. 15. The effect of amiodarone on the high-energy phosphate metabolism in 
Lagendorff-perfused rat hearts. Groups of 5 rats were treated by a single shot of 
physiological salt solution (sham-operated) or amiodarone 20 mg/kg iv. 30 min before 
sacrifice. Their hearts were removed, applied to a Langendorff perfusion apparatus 
which was inserted into the magnet of an NMR spectrometer. Concentrations of 
creatine phosphate (A), ATP (B) and inorganic phosphate (C) were measured in situ 
by 31 p NMR spectroscopy in the perfused hearts subjected to 30 min of ischemia 
followed by 15 min of reperfusion. Data represents average ± S.E.M. Note that the 
time axis is not proportional.
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the recovery of ATP level (45% ± 6 vs. 28% ± 5). The pretreatment with desethylamiodarone 
had no significant effect on the recovery of ATP level (28% ± 5) when compared to control. 
Amiodarone pretreatment facilitated the significantly (p < 0.001) faster and more complete 
utilization of inorganic phosphate (31% ± 6 vs. 62% ± 6) during reperfusion. The 
pretreatment with desethylamiodarone did not prove to be effective in the utilization of 
inorganic phosphate (63% ± 4).
41
Discussion.
We observed that Taxol induced large amplitude swelling of mitochondria, the 
dissipation of mitochondrial membrane potential, opening of the permeability transition pore 
as detected by enzymatic method and on cytochrome-c release, all of which are regarded 
characteristic features of MPT. Our results indicate that Taxol, in a concentration dependent 
manner induced a CsA-sensitive permeability transition in isolated rat liver mitochondria. 
Permeability transition inducing effect of paclitaxel was not tissue specific, since paclitaxel 
induced swelling and dissipation of AT* was demonstrated in mitochondria isolated from not 
only rat liver, but heart, kidney, brain as well as from BRL-3A and HepG-2 cell lines. We 
used isolated mitochondria purified by Percoll-gradient centrifuging to exclude any indirect 
mechanism that could be involved in the effect of paclitaxel on MPT. These indicate, that 
paclitaxel -  apart from previously described mechanisms (Torres and Horowitz, 1998) -  also 
affects the mitochondria through direct interaction. The MPT inducing effect of paclitaxel 
was also verified in cell lines using fluorescent dyes.
Paclitaxel induced ROS formation in isolated mitochondria in a concentration 
dependent manner that could not be inhibited by CsA. Furthermore, the substances that 
attenuated ROS formation did not affect paclitaxel-induced MPT. These results suggest that 
MPT-inducing and ROS formation-inducing effect of paclitaxel in isolated mitochondria are 
mediated by separate mechanisms. Paclitaxel induced ROS formation was about significantly 
more intense in the lipid than in the aquous phase, suggesting that the ROS production was 
localized mainly in the mitochondrial membrane. Paclitaxel induced ROS formation with a 
similar rate either in the presence or absence of respiratory complex inhibitors, except for 
KCN, since in the presence of KCN paclitaxel failed to initiate mitochondrial ROS
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production. These suggests that pactitaxel interfered with the rexod reactions of cytochrome- 
oxidase resulting in a cytochrome-oxidase activity dependent ROS production.
Both amiodarone and desethylamiodarone have damaging effect on extracardiac 
tissues (Amico et al., 1984; Martin and Howard, 1985; Card et al., 1998). While the reports on 
the effect of amiodarone on cardiac functions following ischemia-reperfusion have been 
variable (Nokin et al., 1987; Moreau et al., 1999), there is hardly any data about the effect of 
desethylamiodarone amid these circumstances. Therefore we monitored real time in situ
concentrations of ATP, creatine phosphate and inorganic phosphate during ischemia-
"2 1
reperfiision of Langendorff-perfiised rat hearts by P-NMR spectroscopy. Our results show 
that amiodarone pretreatment resulted in a faster and more complete recovery of the high- 
energy phosphate concentrations and had a significant protecting effect on the energy 
metabolism of perfused hearts during ischemia-reperfusion. It’s effect in preventing the 
ischemia-reperfusion induced release and nuclear translocation of AIF was also observed. 
However desethylamiodarone pretreatment had no protective effect neither on high energy 
phosphates nor on the AIF translocation. Extracardiac cell lines had an enhanced sensitivity 
toward amiodarone toxicity: amiodarone did not present sign of apoptosis in H9C2 cells 
whereas it showed DNA fragmentation in the extracardiac cell line SP-2 in the same 
concentration range. Furthermore, desethylamiodarone also was more toxic than amiodarone 
when tested in all cell lines. The observation, that amiodarone protected the energy 
metabolism in perfused hearts suggested, that the cardioprotectivity of the drug could be 
consequence of it’s direct mitochondrial effect, by influencing the AT, the ROS production, 
the respiration or the MPT. Therefore we studied the direct effect of the drugs on isolated, 
mitochondria from rat liver and heart. Unlike paclitaxel, that induced MPT, we revealed that 
amiodarone has a mixed effect of mitochondrial functions. In low concentrations it stimulated 
state 4 respiration due to an uncoupling effect, inhibited the Ca2+-induced mitochondrial
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swelling, while it dissipated the A'F. However at higher concentrations it exerted and 
inhibitory effect on the mitochondrial respiration, and simultaneously induced a 
mitochondrial swelling, that was not inhibited by CsA. In contrast to this, desethylamiodarone 
did not stimulate state 4 respiration, did not inhibit the Ca2+-induced mitochondrial 
permeability transition and did not induce the collapse of AT* in low concentrations, while at 
higher concentrations, similar to amiodarone, it induced a mitochondrial swelling that was not 
inhibited by CsA and inhibited the respiration. We also found, that FCCP, a widely used 
uncoupling agent, inhibits the Ca2+-induced mitochondrial swelling, while it dissipated the 
AT*. Amiodarone similarly to FCCP exhibits uncoupling effect, inhibits swelling and 
dissipates the A'P. A theory suggests, that during uncoupling, the mitochondrial respiratory 
chain works more efficiently, leading to less leakage of electrons and thus to lower levels of 
ROS generation (Budd et al., 1997), obscuring the mechanism by which FCCP or lower 
membrane potential promotes pore opening. Previous reports (Ribeiro et al., 1997; Di Matola 
et al., 2000), and our findings that amiodarone does not induce ROS production in isolated 
mitochondria is also in accord with this theory.
The beneficial properties of amiodarone are due to the presence of its ethyl group, 
since it’s major metabolite, desethylamiodarone, does not exhibit the cardioprotective and 
beneficial mitochondrial features of the parent drug. In higher concentrations, amiodarone as 
well as desethylamiodarone, besides inhibiting the mitochondrial respiration can induce a 
CsA independent mitochondrial swelling, thus contributing to the toxic property of the drug. 
While both amiodarone and desethylamiodarone have similar antiarrhythmic properties, only 
amiodarone possesses with cardioprotective effect, and the frequently manifesting side effects 
during long-term amiodarone therapy could be related, at least in part, to the accumulation of 
desethylamiodarone.
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